Hypomagnesemia in Chronic Kidney Disease: Problem or Individual Characteristics of Certain Patients?
Journal Title: Нирки - Year 2016, Vol 3, Issue 17
Abstract
The article considers the problem of magnesium deficiency in patients with chronic kidney disease. It requires special attention from clinicians due to the increased risk of cardiovascular complications. The study revealed that one third of patients with chronic kidney disease stages I–III has a magnesium deficiency. The use of magnesium preparations helps to normalize the magnesium homeostasis.
Authors and Affiliations
L. M. Savytska
Keywords
Related Articles
- EP ID EP208323
- DOI 10.22141/2307-1257.3.17.2016.76455
- Views 90
- Downloads 0
Features of renal involvement in systemic connective tissue diseases
Connective tissue diseases (CTDs) are a heterogeneous group of disorders that have certain clinical presentations and a disturbed immunoregulation, leading to autoantibody production. Subclinical or overt renal manifesta...
Kidney Aspects of the Lung Cancer
Metastases in the kidney, perirenal retroperitoneal lymph nodes and adrenal glands occur in 2, 2, and 3 % of patients with lung cancer, respectively, and acute tubulointerstitial nephritis develops in 6 % of cases of rad...
Effect of Albuminuria on the State of Plasma Hemostasis in Patients with Essential Hypertension
In recent decades, numerous scientific works are devoted to the study of the clinical and prognostic significance of albuminuria, methods of its detection, as well as treatment measures aimed at controlling this patholog...
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney dis...
Statins in Nephrology: What does the Guidelines Say?
.